SCHEMBL2811159

SCHEMBL2811159

CC(=COc1ccccc1C)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.44
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
RXRG P48443 1/20 0.41
NOTUM Q6P988 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
PPARG P37231 1/20 0.39
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 2/20 0.38
HTT P42858 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
APEX1 P27695 2/20 0.38
CYP1A2 P05177 1/20 0.38
TSHR P16473 1/20 0.38
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2811157 1.00 AKR1C3 (0.44) AKR1C3RXRARXRBRXRGNOTUM
SCHEMBL6208071 0.83 AKR1C1 (0.44) AKR1C3RXRARXRBRXRGNOTUM
SCHEMBL27374622 0.82 AKR1C3 (0.44) AKR1C3NPSR1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL2809048 0.82 SMN1; SMN2 (0.47) AKR1C3RXRASMN1; SMN2ALDH1A1KDM4E
SCHEMBL2809046 0.82 SMN1; SMN2 (0.47) AKR1C3RXRASMN1; SMN2ALDH1A1KDM4E
SCHEMBL2809730 0.81 NOTUM (0.51) NOTUMSMN1; SMN2ALDH1A1HTTCYP1A2
SCHEMBL2809725 0.81 NOTUM (0.51) NOTUMSMN1; SMN2ALDH1A1HTTCYP1A2
SCHEMBL12851501 0.80 MAPT (0.46) NPSR1SMN1; SMN2ALDH1A1KDM4EHTT
SCHEMBL1920426 0.79 L3MBTL1 (0.43) AKR1C3NPSR1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL147467 0.79 L3MBTL1 (0.43) AKR1C3NPSR1SMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 AKR1C3 18/4885RXRA 117/4885RXRB 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.